Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Bone

PROVIDER: ST002283 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

The 'ForensOMICS' approach for postmortem interval estimation from human bone by integrating metabolomics, lipidomics, and proteomics.

Project description: Not available

| S-EPMC9803353 | biostudies-literature

Plasma Lipidomics and Proteomics Analyses Pre- and Post-5000 m Race in Yili Horses

Project description: Not available

| S-EPMC11987874 | biostudies-literature

A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency.

Project description: Not available

| S-EPMC5278418 | biostudies-literature

Complete Workflow for High Throughput Human Single Skeletal Muscle Fiber Proteomics.

Project description: Not available

| S-EPMC9980124 | biostudies-literature

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.

Project description: Not available

| S-EPMC10163980 | biostudies-literature

Estimating the time of human decomposition based on skeletal muscle biopsy samples utilizing an untargeted LC-MS/MS-based proteomics approach.

Project description: Not available

| S-EPMC10444689 | biostudies-literature

Integrative Proteomics and Lipidomics Analysis of Post-Myocardial Infarction Patients Treated With PCSK9 Antibodies and Statins

Project description:Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition is a potent cholesterol-lowering strategy. This study examined effects of statins and PCSK9 monoclonal antibodies (mAbs) beyond low-density lipoprotein cholesterol reduction, which are not fully defined. To complement in vivo plasma proteomic data, we used HepG2 human hepatoma cells stably expressing apolipoprotein(a) (LPA). Cells were exposed to escalating doses of atorvastatin for ten days, followed by collection of conditioned media and cell lysates for quantitative mass spectrometric analysis. Proteomic profiling of cell lysates revealed a dose-dependent effect on HMG-CoA reductase and other enzymes within the mevalonate pathway. Analysis of conditioned media demonstrated a strong, dose-dependent induction of procollagen C-endopeptidase enhancer 1 (PCOLCE) and a modest increase in secreted LPA. These findings corroborate clinical observations that statin therapy can modestly elevate circulating lipoprotein(a) [Lp(a)] and is associated with increased plasma PCOLCE levels. The HepG2 data provide evidence for a predominant hepatic origin of this PCOLCE response, representing a novel mechanistic insight into statin-associated proteomic changes.

2026-04-27 | PXD069776 | Pride

Unraveling the Molecular Landscape of SCN1A Gene Knockout in Cerebral Organoids: A Multiomics Approach Utilizing Proteomics, Lipidomics, and Transcriptomics.

Project description: Not available

| S-EPMC11425820 | biostudies-literature

Effects of elaidic acid on lipid metabolism in HepG2 cells, investigated by an integrated approach of lipidomics, transcriptomics and proteomics.

Project description: Not available

| S-EPMC3772929 | biostudies-literature

Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach.

Project description: Not available

| S-EPMC6801960 | biostudies-literature